Skip to content

Effect of air versus local anaesthetic drug used for artificial respiratory tube bulb inflation on coughing and respiratory passage complains after removing artificial respiratory tube in patients undergoing surgeries with laparoscopic devices

Effect of air versus 1% xylocard used for endotracheal tube cuff inflation on coughing and laryngotracheal morbidity after tracheal extubation in patients undergoing laparoscopic surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036245
Enrollment
54
Registered
2021-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 1% xylocard: Endotracheal tube cuff inflation will be done with 4-6cc 1% xylocard Control Intervention1: Air: Endotracheal tube cuff inflation will be done with 4-6cc air

Sponsors

Shree Krishna Hospital and Pramukhswami Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All laparoscopic surgeries with ASA grade I, II, III Duration of surgery: 1-4 hours

Exclusion criteria

Exclusion criteria: 1)h/o laryngotracheal diseases 2)oropharyngeal airway introduced peri-operatively 3) >2 trial of intubation 4)h/o raised intraocular pressure, intracranial pressure 5)h/o recent urti 6)h/o gastric regurgitation 7)anticipated difficult airway

Design outcomes

Primary

MeasureTime frame
Postoperative complications like sore throat, hoarseness of voice and dysphagiaTimepoint: 2 hours and 18-24 hours

Secondary

MeasureTime frame
Post extubation coughingTimepoint: Immediately post extubation

Countries

India

Contacts

Public ContactDr Surani Himali

Shree Krishna Hospital and Pramukhswami Medical College

birvank@charutarhealth.org9537122077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026